Search

Author/Creator O'Brien, Meagan P.

1. A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy. (19th January 2017)

Authors:
O'Brien, Meagan P.; Hunt, Peter W.; Kitch, Douglas W.; Klingman, Karin; Stein, James H.; Funderburg, Nicholas T.; Berger, Jeffrey S.; Tebas, Pablo; Clagett, Brian; Moisi, Daniela; Utay, Netanya S.; Aweeka, Fran; Aberg, Judith A.
Journal:
Open forum infectious diseases
Issue:
Volume 4:Number 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV‐2. Issue 6 (20th September 2022)

Authors:
Kamal, Mohamed A.; Kuznik, Andreas; Qi, Luyuan; Więcek, Witold; Hussein, Mohamed; Hassan, Hazem E.; Patel, Kashyap; Obadia, Thomas; Toroghi, Masood Khaksar; Conrado, Daniela J.; Al‐Huniti, Nidal; Casciano, Roman; O'Brien, Meagan P.; Barnabas, Ruanne V.; Cohen, Myron S.; Smith, Patrick F.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 112:Issue 6(2022)
Page Start:
1224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cat allergen exposure in a naturalistic exposure chamber: A prospective observational study in cat‐allergic subjects. Issue 2 (14th January 2022)

Authors:
Yang, William H.; Kelly, Suzanne; Haya, Laura; Mehri, Rym; Ramesh, Divya; DeVeaux, Michelle; Wang, Claire Q.; Meier, Pretty; Narula, Sumit; Shawki, Furat; Pennington, Ryan; Perlee, Lorah; O'Brien, Meagan P.
Journal:
Clinical & experimental allergy
Issue:
Volume 52:Issue 2(2022)
Page Start:
265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022)

Authors:
Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 10(2022)
Page Start:
1444
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19. (September 2022)

Authors:
Isa, Flonza; Forleo-Neto, Eduardo; Meyer, Jonathan; Zheng, Wenjun; Rasmussen, Scott; Armas, Danielle; Oshita, Masaru; Brinson, Cynthia; Folkerth, Steven; Faria, Lori; Heirman, Ingeborg; Sarkar, Neena; Musser, Bret J.; Bansal, Shikha; O'Brien, Meagan P.; Turner, Kenneth C.; Ganguly, Samit; Mahmood...
Journal:
International journal of infectious diseases
Issue:
Volume 122(2022)
Page Start:
585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗